Published in Oncogene on August 09, 2010
Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood (2011) 2.16
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma. Cancer Cell (2012) 1.49
The role of polo-like kinase 1 in carcinogenesis: cause or consequence? Cancer Res (2013) 1.11
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov (2014) 1.10
EZH2 couples pancreatic regeneration to neoplastic progression. Genes Dev (2012) 1.07
LKB1 loss in melanoma disrupts directional migration toward extracellular matrix cues. J Cell Biol (2014) 0.97
Targeting the Checkpoint to Kill Cancer Cells. Biomolecules (2015) 0.94
Genetics of melanoma. Front Genet (2013) 0.91
Current State of Animal (Mouse) Modeling in Melanoma Research. Cancer Growth Metastasis (2015) 0.91
Narrowing the knowledge gaps for melanoma. Ups J Med Sci (2012) 0.84
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat Med (2016) 0.83
CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1. J Invest Dermatol (2013) 0.81
Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma. Chin J Cancer (2011) 0.79
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Small GTPases (2010) 0.76
Clinical and Histopathological Characteristics between Familial and Sporadic Melanoma in Barcelona, Spain. J Clin Exp Dermatol Res (2014) 0.75
Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth. Mol Cancer Res (2016) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature (2001) 10.56
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet (2001) 9.55
The regulation of INK4/ARF in cancer and aging. Cell (2006) 8.75
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell (2004) 8.16
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet (2009) 7.81
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (1998) 6.62
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol (2006) 6.06
Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell (2007) 6.02
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature (2003) 6.01
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
COSMIC 2005. Br J Cancer (2006) 5.07
The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol (2001) 4.83
Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell (2008) 4.71
Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev (2006) 4.24
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature (2007) 3.26
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol (2009) 2.91
Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science (2004) 2.81
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Neonatal sunburn and melanoma in mice. Nature (2001) 2.25
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis (2006) 1.85
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res (2005) 1.84
Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res (2007) 1.77
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
Cellular senescence: hot or what? Curr Opin Genet Dev (2009) 1.68
Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development (1989) 1.64
PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development (2002) 1.64
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. Cancer Res (2007) 1.62
BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene (2004) 1.58
CD200 is induced by ERK and is a potential therapeutic target in melanoma. J Clin Invest (2007) 1.45
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci U S A (2003) 1.32
Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Res (2007) 1.32
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A (1996) 1.31
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene (2003) 1.29
Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res (1994) 1.24
Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation. J Biol Chem (2000) 1.22
Sun exposure and melanocytic naevi in young Australian children. Lancet (1994) 1.15
Effects of the developmental colour mutations silver and recessive spotting on proliferation of diploid and immortal mouse melanocytes in culture. Development (1992) 1.12
A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene (2001) 1.11
p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. Br J Cancer (1999) 1.08
p53 gene mutation and expression in naevi and melanomas. Melanoma Res (1995) 1.05
Germline mutation of ARF in a melanoma kindred. Hum Mol Genet (2002) 1.04
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer (1998) 1.04
Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival. Clin Cancer Res (2005) 0.98
p16(INK4a) and p53 deficiency cooperate in tumorigenesis. Cancer Res (2002) 0.96
CDKN2A (p16INK4A) somatic and germline mutations. Hum Mutat (1996) 0.93
Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int J Cancer (1998) 0.91
Childhood malignant melanoma. Incidence and etiology. Am J Pediatr Hematol Oncol (1985) 0.85
Sun protection and the development of melanocytic nevi in children. Cancer Epidemiol Biomarkers Prev (2005) 0.84
Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64
7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med (2001) 7.05
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature (2000) 4.75
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (2000) 3.83
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell (2000) 3.82
Self-regulation in the modification of disruptive classroom behavior. J Appl Behav Anal (1972) 3.62
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. Proc Natl Acad Sci U S A (1989) 2.92
Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem (1999) 2.89
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med (2001) 2.87
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet (2001) 2.76
Laparoscopic cholecystectomy, bile duct injury and the British and Irish surgeon. Ann R Coll Surg Engl (1998) 2.66
Value of graduated compression stockings in deep venous insufficiency. Br Med J (1980) 2.65
Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrob Agents Chemother (1998) 2.59
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet (1997) 2.56
Cytokinin action is coupled to ethylene in its effects on the inhibition of root and hypocotyl elongation in Arabidopsis thaliana seedlings. Plant Physiol (1995) 2.52
Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology (2000) 2.50
Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol (1993) 2.46
Receptor-mediated transport of insulin across endothelial cells. Science (1985) 2.42
Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology (2009) 2.41
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat Med (2005) 2.28
Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection. Antimicrob Agents Chemother (2001) 2.24
Problem-based learning: its rationale and efficacy. Med J Aust (1998) 2.18
Large-scale concatenation cDNA sequencing. Genome Res (1997) 2.18
Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science (1999) 2.14
In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol (2005) 2.07
Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob Agents Chemother (1990) 2.03
Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology (2008) 2.00
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene (1998) 1.98
Multiple-locus departures from panmictic equilibrium within and between village gene pools of Amerindian tribes at different stages of agglomeration. Genetics (1983) 1.93
Effect of conjugated linoleic acid on body composition in mice. Lipids (1997) 1.92
Transgenic mouse model for skin malignant melanoma. Oncogene (1998) 1.90
Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents. Cardiovasc Res (1999) 1.89
Slow synaptic potentials in neurones of the myenteric plexus. J Physiol (1980) 1.87
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J (2001) 1.86
Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res (2000) 1.86
Dissection of the enhancer activity of beta-globin 5' DNase I-hypersensitive site 2 in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.84
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet (1999) 1.83
A "double adaptor" method for improved shotgun library construction. Anal Biochem (1996) 1.81
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res (2001) 1.80
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res (2001) 1.80
Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. RNA (1999) 1.78
Timeout duration and the suppression of deviant behavior in children. J Appl Behav Anal (1972) 1.78
Regulation of left-right asymmetry by thresholds of Pitx2c activity. Development (2001) 1.77
Respiratory rhythm generation in neonatal and adult mammals: the hybrid pacemaker-network model. Respir Physiol (2000) 1.76
Multiple assessment of behavior modification with families: effects of contingency contracting and order of treated problems. J Consult Clin Psychol (1974) 1.76
p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A (2001) 1.75
Prevalence of helminths in water buffaloes in Hunan Province, China. Trop Anim Health Prod (2008) 1.72
Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. Biophys J (2004) 1.71
Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation. J Biol Chem (2000) 1.70
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial. J Infect Dis (2007) 1.70
The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences. Neuroscience (2003) 1.69
Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst (1996) 1.69
Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem (1999) 1.68
The slow calcium-dependent potassium current in a myenteric neurone of the guinea-pig ileum. J Physiol (1985) 1.67
Terahertz response and colossal Kerr rotation from the surface states of the topological insulator Bi2Se3. Phys Rev Lett (2012) 1.67
Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system. Dev Dyn (2005) 1.66
Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry (2010) 1.66
Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol (1999) 1.65
Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.63
The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol (2000) 1.63
In meso structure of the cobalamin transporter, BtuB, at 1.95 A resolution. J Mol Biol (2006) 1.62
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet (1999) 1.61
Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J (2006) 1.61
Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem (1997) 1.61
Chloride secretory mechanism induced by prostaglandin E1 in a colonic epithelial cell line. J Clin Invest (1985) 1.61
Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor. Am J Physiol (1998) 1.60
Pho signal transduction network reveals direct transcriptional regulation of one two-component system by another two-component regulator: Bacillus subtilis PhoP directly regulates production of ResD. Mol Microbiol (1998) 1.60
Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer (2000) 1.58
Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am J Hum Genet (1999) 1.56
Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol (1999) 1.54
Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet (1997) 1.53
Multilayer PDMS microfluidic chamber for controlling brain slice microenvironment. Lab Chip (2007) 1.52
Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia. Lancet (1977) 1.52
Cloning and functional expression of a cDNA encoding a pheromone gland-specific acyl-CoA Delta11-desaturase of the cabbage looper moth, Trichoplusia ni. Proc Natl Acad Sci U S A (1998) 1.52
Urethral seam formation and hypospadias. Cell Tissue Res (2001) 1.50
Potassium permeability of single compartment liposomes with and without valinomycin. Biochim Biophys Acta (1969) 1.50
Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg (1979) 1.50
Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res (1998) 1.49
Retinal prosthesis: an encouraging first decade with major challenges ahead. Ophthalmology (2001) 1.48
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol (1993) 1.48
A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem Biophys (2007) 1.48
Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant (2009) 1.48
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer (2001) 1.47
Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model. Eur J Cancer (2002) 1.47
Mechanism of action of Escherichia coli heat stable enterotoxin in a human colonic cell line. J Clin Invest (1988) 1.47
Inhibition of neutrophil activation by ranitidine contributes to prevent stress-induced gastric mucosal injury in rats. Crit Care Med (2000) 1.46
Epigenetic interactions and the structure of phenotypic variation in the cranium. Evol Dev (2007) 1.45
Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr (1999) 1.45
Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China. J Virol (2007) 1.44
The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem (1999) 1.44
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet (2005) 1.44
Do negative CCT and CSF findings exclude a subarachnoid haemorrhage? A retrospective analysis of 220 patients with subarachnoid haemorrhage. Eur J Neurol (2011) 1.42
Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum. J Biol Chem (2000) 1.41
Brn3a is a transcriptional regulator of soma size, target field innervation and axon pathfinding of inner ear sensory neurons. Development (2001) 1.41
Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24. Genomics (1999) 1.41